MYX mayne pharma group limited

Getting back to the original question - The MYX chart appears to...

  1. 385 Posts.
    lightbulb Created with Sketch. 231
    Getting back to the original question - The MYX chart appears to be showing what's technically known as bumping along the bottom. It's definitely not an uptrend.
    there are 2 things that can change this situation and make the share price increase.
    1. Nuvaring generic approval. The current timeline is this is maybe a possibility in the second half of this year but we've heard that before.
    2. Nextstellis approval. They're hoping this will come in April. But again MYX management's track record and inability to get anything approved by FDA means that it will require an actual approval letter to be received before any investors believe it.

    As a MYX shareholder - TEVA getting the second approval for generic Nuvaring sucks. I really get the feeling that Scott Richards wants us all to forget about Nuvaring and look at Nextstellis while he crosses his fingers and toes he can get that one approved. I think Patrick31's description of SR as a carrot dangler is perfect. All he's done in the past 3-4 years is dangle carrots. He certainly hasn't been getting anything approved by the FDA.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.25
Change
-0.150(2.78%)
Mkt cap ! $426.5M
Open High Low Value Volume
$5.35 $5.41 $5.19 $1.239M 231.7K

Buyers (Bids)

No. Vol. Price($)
1 1000 $5.17
 

Sellers (Offers)

Price($) Vol. No.
$5.36 1000 1
View Market Depth
Last trade - 16.11pm 25/07/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.